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Abstract
 
Oxidant-induced injury to the lung causes extensive damage to lung epithelial cells. Impaired
protection and repair of the lung epithelium can result in death. The serine-threonine kinase
Akt has been implicated in inhibiting cell death induced by different stimuli including growth
factor withdrawal, cell cycle discordance, DNA damage, and loss of cell adhesion in different
cell types. However, the in vivo relevance of this prosurvival pathway has not been explored.
Here we show that a constitutively active form of Akt introduced intratracheally into the lungs
of mice by adenovirus gene transfer techniques protects mice from hyperoxic pulmonary dam-
age and delays death of mice. This is the first demonstration of the in vivo protective function
of Akt in the context of oxidant-induced lung injury.
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Introduction
 
Oxygen therapy is administered to decrease tissue hypoxia
and to relieve arterial hypoxemia in patients with acute and
chronic cardiovascular and pulmonary diseases and also to
premature babies with respiratory distress syndrome. How-
ever, hyperoxia can cause acute lung injury which results in
increased lung water with protein-rich edema fluid spilling
into the interstitial and alveolar spaces. This is thought to
occur after injury to epithelial and capillary endothelial cells
resulting in epithelial cell death and increased pulmonary
capillary permeability (1, 2). Current evidence indicates
that the damaging effects of oxygen are caused by reactive
oxygen intermediates (ROIs) such as the superoxide anion
 
(O
 
2
 
2
 
) that are formed in the presence of excessive oxygen.
Severe oxidant-induced stress can result in respiratory fail-
ure and even death (3).
 
Akt/PKB is homologous to the protein kinases PKA and
PKC (and hence the name PKB or related to A and C pro-
tein kinase [RAC-PK]; reference 4). Akt is activated by
phosphatidylinositol (PI) 3-kinase in response to growth
and survival factors (5). It has been shown that after stimula-
tion by growth factors, Akt undergoes phosphorylation at
residues Thr308 in the activation loop of the kinase and at
Ser473 in the carboxy terminus (6, 7). A downstream path-
way that is induced by activation of the PI 3-kinase/Akt
pathway is the phosphorylation of the Bcl-2 family member
Bad, which releases Bcl-XL thereby promoting cell survival
(8, 9). A second downstream prosurvival mechanism in-
volves the transcription factor forkhead, the phosphoryla-
tion of which by Akt prevents its nuclear translocation and
activation of genes that promote apoptosis (10). Several
studies indicate that Akt activation plays an important role
in inhibiting cell apoptosis in fibroblasts, epithelial and lym-
phoid cell lines, and neuronal cells (11–16). However, these
studies with Akt have been carried out in vitro and the in
vivo significance of this pathway in protection from cell
death induced by different stimuli including oxidative stress
remains to be investigated. Here we demonstrate that ex-
pression of a constitutively active derivative of Akt in the
mouse lung by adenovirus gene transfer methods protects
lungs and delays death from oxidant-induced injury.
 
Materials and Methods
 
Cells and Adenovirus Constructs.
 
Human primary small air-
way epithelial (SAE) cells were obtained from Clonetics and
grown in supplied medium. The virus packaging cell line 293
was grown in DMEM supplemented with 10% FBS. The gener-
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ation of adenovirus constructs expressing myr-Akt has been de-
scribed previously (17).
 
Akt Kinase Assay.
 
Akt kinase assay was performed using an
“Akt Kinase Assay” kit (Cell Signaling Technology) following
the manufacturer’s instructions. In brief, SAE cells grown in
100-mm plates were infected by Adeno-myr-Akt virus or con-
trol Adeno-green fluorescent protein (GFP) virus at a multiplic-
ity of infection (MOI) of 10. Cells were lysed in immunoprecip-
itation (IP) buffer and used for immunoprecipitation of Akt with
anti-Akt antibody conjugated to agarose beads. The immunopre-
cipitated Akt was incubated with glycogen synthase kinase
(GSK)-3 protein in kinase assay buffer containing ATP. After
centrifugation, an aliquot of the supernatant was removed and
tested for the presence of phospho-GSK-3 by Western blotting
 
using anti–phospho-GSK-3
 
a
 
/
 
b
 
(Ser 21/9) antibody. The Akt
bound to the agarose beads was released by boiling in SDS-sam-
ple buffer and subjected to Western blot analysis using anti-Akt
antibody.
 
Exposure of Mice to Hyperoxic Stress and Intratracheal Administra-
tion of Adenovirus.
 
To address the role of Akt in protection from
hyperoxic injury in vivo, a constitutively active form of Akt
 
(myr-Akt; reference 17) was instilled into the trachea of C57BL/6
 
mice (7–9 wk old). Mice were anesthetized by intraperitoneal
injection of a 0.1-ml solution of a ketamine/xylazine mixture (10
mg/ml/1 mg/ml) in pyrogen-free saline. The skin of the mice on
the ventral neck was cleaned with a cotton swab soaked in iso-
propyl alcohol. The mice were next placed on a Deltaphase Iso-
 
thermal pad (Braintree Scientific Inc.) warmed up to 37
 
8
 
C to re-
duce hypothermia and quicken recovery time. Trachea were
exposed by a small incision in the neck skin. Next, 50 
 
m
 
l of PBS
containing adenovirus (Ad-myr-Akt or Ad-EGFP, 10
 
9
 
 PFU) was
injected into the trachea using a 50-
 
m
 
l Hamilton syringe fitted
with a 22 S needle. The incision was closed with wound clips and
mice were kept warm and monitored until they recovered from
anesthesia (usually 30 min). Then they were transferred to their
cages with food and water and the cages were transferred to a hy-
peroxic chamber and exposed to 100% oxygen in a plexiglass hy-
peroxia exposure chamber. Oxygen from a liquid source was
passed through a bubble humidifier and introduced into the
sealed chamber at 10 liters/min. The chamber was fitted with a
water manometer to maintain normobaric pressure. CO
 
2
 
 produc-
tion by the animals was neutralized in the chamber by absorbing
with soda lime filter. The FIO
 
2
 
 was measured continuously with
an oxygen analyzer (VTI O
 
2
 
 gas analyzer; Vacu Med). The mice
were fed food and water ad lib and maintained on a 12-h dark-
light cycle at sea level and at room temperature. Mice were fol-
lowed after exposure to O
 
2 
 
for different lengths of time and as-
sessed for hyperoxic injury.
 
Lung Histology.
 
Lungs were prepared for histology by perfus-
ing the animal through the right ventricle with PBS to remove all
blood as described by us previously (18, 19). Lungs were inflated
to 20 cm water pressure with Streck Tissue Fixative (STF; Streck
Laboratories Inc.) instilled through a tracheostomy tube. 5-
 
m
 
M
sections were mounted on slides and stained with hematoxylin
and eosin according to established procedures.
 
Terminal Deoxynucleotidyl Transferase–mediated dUTP-biotin Nick-
 
end Labeling Assay.
 
DNA fragmentation was assessed using
 
the DeadEnd Colorimetric Apoptosis Detection System
(Promega). Tissue sections were deparaffinized by immersing
slides in fresh xylene, washed successively in graded ethanol, and
subjected to terminal deoxynucleotidyl transferase–mediated
dUTP-biotin nick-end labeling (TUNEL) assay following in-
structions of the manufacturer. Negative controls were incu-
bated in buffer containing all components except TdT enzyme.
Nucleotide incorporation was detected by treatment with
horseradish peroxidase–conjugated streptavidin and enzyme
substrate.
 
Statistical Analysis.
 
Where appropriate, data are expressed as
means 
 
6
 
 SEM. The significance of difference between two
groups was analyzed using the Student’s unpaired 
 
t
 
 test. Differ-
ences in means were considered significant if
 
 P 
 
,
 
 0.05. Differ-
ences in survival between mice infected with control virus and
Akt-expressing virus were assessed by 
 
x
 
2
 
 analysis.
Figure 1. Constitutively ac-
tive Akt induces phosphorylation
of downstream substrates fork-
head and Bad in lung epithelial
cells. SAE cells were infected
with HA-tagged Ad-myr-Akt
virus or Ad-con virus. After 24 h
of infection, cells were washed
and lysed as described in Materi-
als and Methods. (A) Cell ex-
tracts were used to determine
Akt kinase activity.   Endoge-
nous Akt and Akt expressed
from the transgene were immu-
noprecipitated with the same
amount of anti-Akt antibody and
the kinase activity in the immu-
noprecipitate was determined us-
ing GSK-3 as substrate. The re-
action mixtures were centrifuged
and the phosphorylation of
GSK-3 in the supernatant was
assessed by immunoblotting using anti–phospho-GSK-3a/b(Ser 21/9) an-
tibody. (B) The phosphorylation of downstream substrates of Akt, fork-
head, and Bad was determined by sequential immunoprecipitation and
Western blot analysis. Forkhead and Bad were immunoprecipitated with
anti-forkhead antibody (Cell Signaling Technology) and anti-Bad anti-
body (Santa Cruz Biotechnology, Inc.), respectively. Immunoprecipitates
were collected by centrifugation, washed four times with IP buffer, and
subjected to Western blot analysis with anti–phospho-Bad antibody (Ser
136; Cell Signaling Technology) or anti–phospho-forkhead antibody (Ser
256; Cell Signaling Technology).
Figure 2. Constitutively active Akt delays death of hyperoxic mice.
Mice were infected intratracheally with Ad-con or Ad-myr-Akt and then
exposed to 100% oxygen. The survival of the mice was followed after ini-
tiation of hyperoxic exposure. In each experiment, each group consisted
of 10 animals. Mice expressing Ad-myr-Akt showed a significant increase
in survival time in all three experiments (P , 0.0001, P , 0.0003, and
P , 0.0001 in experiments 1, 2, and 3, respectively). The data of three
independent experiments are shown. 
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Results and Discussion
 
A Constitutively Active Form of Akt Can Phosphorylate Its
Downstream Substrates Bad and Forkhead in Lung Epithelial
Cells.
 
In cell culture systems, activation of Akt has been
shown to result in phosphorylation of protein substrates that
are involved in cytoprotection. To study the in vivo func-
tion of activated Akt, we generated replication-defective
adenovirus containing a constitutively active form of Akt
(myristoylated Akt; Ad-myr-Akt). The functional activity
of myr-Akt was assessed by infecting primary SAE cells
with either Ad-myr-Akt or control replication-defective
 
adenovirus (Ad-con) and by performing Akt kinase assay by
immunoprecipitating Akt from cell extracts and using GSK-3
as substrate. Fig. 1 A demonstrates that myr-Akt is an active
kinase as revealed by phosphorylation of GSK-3. One
mechanism by which Akt promotes cell survival involves
phosphorylation of the Bcl-family member Bad (8, 9).
Phosphorylation of Bad at Ser-136 by Akt results in its dis-
sociation from Bcl-X
 
L
 
 and association with the adapter pro-
tein 14-3-3. The free Bcl-X
 
L
 
 released from sequestration by
Bad promotes cell survival. Another downstream substrate
of activated Akt involved in cell survival is the transcription
factor forkhead (10). Phosphorylation of forkhead by Akt
Figure 3. Constitutively active Akt inhibits hyperoxic lung injury in mice. (A) C57BL/6
mice were infected intratracheally with 109 PFU of either control virus (Ad-EGFP) or Ad-
myr-Akt (HA tagged) and then exposed to 100% O2. Lungs were prepared for histology by
perfusing the animal through the right ventricle with PBS to remove all blood. Lungs were
then inflated to constant pressure (20 cm water) with Streck Tissue fixative (Streck Labs.) in-
stilled through a tracheostomy tube. 5-mM lung sections were mounted on slides and
stained with hematoxylin and eosin according to established procedures. All of the control
mice died by 72 h of O2 exposure and displayed hyaline membrane formation (white ar-
rows), edema (black arrow), widening of alveolar septae (asterisk), and widespread inflam-
mation and hemorrhage (left), whereas none of the mice expressing myr-Akt died at 72 h of
initiation of O2 exposure and also had no signs of lung injury at this time point (middle). Mice expressing myr-Akt displayed hyaline membrane forma-
tion, patchy edema, and hemorrhage at later time points (z120 h after hyperoxia; right). (B) Expression of constitutively active, HA epitope–tagged Akt
in mouse lungs at different times of hyperoxic exposure. Lung homogenates were prepared and immunoprecipitations were carried out with anti-HA an-
tibody coupled to agarose followed by Western blot analysis using antibody against phospho-Akt. As myristoylation of Akt causes constitutive phosphor-
ylation of Akt, the increased level of phospho-Akt with time was a reflection of increased level of protein expression from the transgene as confirmed by
stripping the blot and reprobing with anti-Akt antibody. This experiment was repeated twice with similar results.
Figure 4. Inhibition of cell
death in the airway epithelium
by expression of constitutively
active Akt (Ad-myr-Akt). (A)
Lung sections from mice in-
fected with control adenovirus
or Ad-myr-Akt were subjected
to TUNEL assay for detection of DNA fragmentation/cell death in lung tissue. Lung sections were deparaffinized. Sections were then subjected to
TUNEL assay (Dead End; Promega) following instructions of the manufacturer. Brown staining of the cells represent apoptotic nuclei. (B) A quantitative
estimate of apoptotic nuclei (brown stain) per unit area. At 72, 96, and 120 h after hyperoxic treatment, there was a significant suppression of airway ep-
ithelial cell death in mice expressing myr-Akt compared with mice infected with control virus at 72 h after hyperoxia (*P , 0.001, **P , 0.0134, and
***P , 0.035). 
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inhibits its apoptotic function by preventing its nuclear
translocation. Fig. 1, B and C, show the ability of myr-Akt
to cause phosphorylation of Bad and forkhead. Therefore,
these data show that myr-Akt is able to phosphorylate its
signaling substrates that are involved in cytoprotection.
 
Constitutively Active Akt Prolongs Survival of Hyperoxic Mice
and Inhibits Oxidant-induced Injury to the Lung.
 
Having
confirmed the ability of myr-Akt to induce activation of
downstream signaling pathways in lung epithelial cells, we
investigated whether expression of Ad-myr-Akt could pre-
vent oxidant-induced lung injury and death in animals. In
these experiments, control adenovirus or adenovirus ex-
pressing myr-Akt (17) was introduced intratracheally into
mice and the mice were immediately exposed to 100% O
 
2
 
.
Although all of the control mice died within 72 h of initia-
tion of exposure to 100% O
 
2
 
, all of the mice infected with
Ad-myr-Akt lived longer (Fig. 2). The mice were killed at
120 h at which point they had begun to display respiratory
distress. Thus, mice expressing activated Akt showed a sig-
nificant increase in survival time (
 
P
 
 
 
,
 
 0.0001). Histological
examination of lung sections showed hyaline membrane
formation, hemorrhage, inflammation, and gross pulmonary
edema in the lungs of the control mice at 72 h (Fig. 3 A). In
contrast, the lungs of mice infected with Ad-myr-Akt ap-
peared normal and free of any hyaline membrane, hemor-
rhage, inflammation, or edema at 72 h after hyperoxia. At
120 h of exposure to 100% O
 
2
 
, the lungs of the myr-Akt–
expressing mice displayed hyaline membrane formation,
hemorrhage, inflammation, and edema. To confirm expres-
sion and activation of myr-Akt in the lungs of the infected
mice, lung extracts were immunoprecipitated with anti-hem-
agglutinin (HA) antibody and the immunoprecipitates were
analyzed by immunoblotting with antibody to phosphory-
lated Akt. As shown in Fig. 3 B, adenovirus-derived trans-
genic expression of activated Akt was evident within 24 h of
infection in mice infected with Ad-myr-Akt but not in
those infected with the control virus, and the expression was
detectable at 96 h after infection, the last time point tested in
this assay. It is well established that hyperoxic injury involves
an initiation phase after exposure to hyperoxia which is fol-
lowed by an inflammatory phase and a destructive phase.
Collectively, our data suggest that activated Akt can signifi-
cantly delay the initiation phase of acute lung injury.
 
Constitutively Active Akt Protects Lung Epithelial Cell Death
In Vivo.
 
We next examined whether expression of con-
stitutively active Akt is sufficient to suppress cell death in-
duced by hyperoxia. In these experiments, lung sections
from mice infected with control adenovirus or adenovirus
expressing constitutively active Akt were subjected to
TUNEL assay for nuclear DNA fragmentation, an indica-
tor of cell death. As shown in Fig. 4 A, mice infected with
control virus and subjected to hyperoxia displayed exten-
sive TUNEL
 
1
 
 nuclei in the airway epithelium as well as in
alveolar epithelial cells at 72 h after hyperoxia. In contrast,
at this time point, cell death in the airway epithelium was
almost completely blocked and alveolar epithelial cell death
was partially blocked when mice were infected with Ad-
myr-Akt. The better protection of the airway epithelium
 
was probably due to the fact that the airway epithelium is
more accessible to adenovirus mediated gene transfer than
the alveolar epithelium. At 120 h after exposure to hyper-
oxia, when hemorrhage, inflammation, and edema were
evident in the lungs of the Ad-myr-Akt–infected mice
(Fig. 4 A), correspondingly, cell death was apparent in both
airway and alveolar epithelial cells. Thus, the increased sur-
vival of Ad-myr-Akt–expressing animals at 72 h after hy-
peroxia correlated with decreased hemorrhage, inflamma-
tion, and edema in the lung and a dramatic suppression of
airway cell death. These results suggest that a better means
of activating Akt in alveolar epithelial cells will provide a
better survival advantage to the animals.
In summary, our data demonstrate that Akt activation in
vivo promotes resistance to oxidant-induced cell death and
significantly delays the onset of acute lung injury resulting
in increased survival of animals. Recently, activation of Akt
by the 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase
inhibitor simvastatin was shown to promote angiogenesis in
the ischemic limbs of normocholesterolemic animals (20).
Similarly, Akt activation may be a useful adjunct to oxygen
therapy in hypoxic stress in cardiovascular and pulmonary
diseases.
 
The authors thank R. Homer for advice on lung pathologies and
members of the Yale Pulmonary Section for helpful discussions.
This work was supported by grants HL60207 and HL60995
from the National Institutes of Health to P. Ray.
 
Submitted: 22 November 2000
Revised: 21 December 2000
Accepted: 3 January 2001
 
References
 
1. Jackson, R.M. 1985. Pulmonary oxygen toxicity. 
 
Chest. 
 
88:
900–905.
2. Jenkinson, S.G. 1993. Oxygen toxicity. 
 
New Horiz.
 
 1:504–
511.
3. Baldwin, S.R., R.H. Simon, C.M. Grum, L.H. Ketai, L.A.
Boxer, and L.J. Devall. 1986. Oxidant activity in expired
breath of patients with adult respiratory distress syndrome.
 
Lancet.
 
 1:11–14.
4. Franke, T.F., D.R. Kaplan, and L.C. Cantley. 1997. PI3K:
downstream AKTion blocks apoptosis. 
 
Cell.
 
 88:435–437.
5. Chan, T.O., S.E. Rittenhouse, and P.N. Tsichlis. 1999.
AKT/PKB and other D3 phosphoinositide-regulated kinases:
kinase activation by phosphoinositide-dependent phosphory-
lation. 
 
Annu. Rev. Biochem. 
 
68:965–1014.
6. Bellacosa, A., T.O. Chan, N.N. Ahmed, K. Datta, S. Mal-
strom, D. Stokoe, F. McCormick, J. Feng, and P. Tsichlis.
1998. Akt activation by growth factors is a multiple-step pro-
cess: the role of the PH domain. 
 
Oncogene.
 
 17:313–325.
7. Alessi, D.R., M. Andjelkovic, B. Caudwell, P. Cron, N.
Morrice, P. Cohen, and B.A. Hemmings. 1996. Mechanism
of activation of protein kinase B by insulin and IGF-1.
 
EMBO (Eur. Mol. Biol. Organ.) J.
 
 15:6541–6551.
8. Datta, S.R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh,
and M.E. Greenberg. 1997. Akt phosphorylation of BAD
couples survival signals to the cell-intrinsic death machinery.
 
Cell.
 
 91:231–241. 
549
 
Lu et al. Brief Definitive Report
9. del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and
G. Nunez. 1997. Interleukin-3-induced phosphorylation of
BAD through the protein kinase Akt. 
 
Science.
 
 278:687–689.
10. Brunet, A., A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S.
Hu, M.J. Anderson, K.C. Arden, J. Blenis, and M.E. Green-
berg. 1999. Akt promotes cell survival by phosphorylating
and inhibiting a Forkhead transcription factor. 
 
Cell.
 
 96:857–
868.
11. Ahmed, N.N., H.L. Grimes, A. Bellacosa, T.O. Chan, and
P.N. Tsichlis. 1997. Transduction of interleukin-2 antiapop-
totic and proliferative signals via Akt protein kinase. 
 
Proc.
Natl. Acad. Sci. USA. 
 
94:3627–3632.
12. Kulik, G., A. Klippel, and M.J. Weber. 1997. Antiapoptotic
signalling by the insulin-like growth factor I receptor, phos-
phatidylinositol 3-kinase, and Akt. 
 
Mol. Cell. Biol.
 
 17:1595–
1606.
13. Kennedy, S.G., A.J. Wagner, S.D. Conzen, J. Jordan, A. Bel-
lacosa, P.N. Tsichlis, and N. Hay. 1997. The PI 3-kinase/
Akt signaling pathway delivers an anti-apoptotic signal. 
 
Genes
Dev.
 
 11:701–713.
14. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C.
Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Sup-
pression of c-Myc-induced apoptosis by Ras signalling
through PI(3)K and PKB. 
 
Nature.
 
 385:544–548.
15. Dudek, H., S.R. Datta, T.F. Franke, M.J. Birnbaum, R.
Yao, G.M. Cooper, R.A. Segal, D.R. Kaplan, and M.E.
Greenberg. 1997. Regulation of neuronal survival by the
serine-threonine protein kinase Akt. 
 
Science. 
 
275:661–665.
16. Hemmings, B.A. 1997. Akt signaling: linking membrane
events to life and death decisions. 
 
Science. 
 
275:628–630.
17. Fujio, Y., and K. Walsh. 1999. Akt mediates cytoprotection
of endothelial cells by vascular endothelial growth factor in
an anchorage-dependent manner. 
 
J. Biol. Chem.
 
 274:16349–
16354.
18. Ray, P., W.L. Tang, P. Wang, R. Homer, C. Kuhn, III,
R.A. Flavell, and J.A. Elias. 1997. Regulated overexpression
of interleukin 11 in the lung: use to dissociate development-
dependent and -independent effects. 
 
J. Clin. Invest.
 
 100:
2501–2511.
19. Yang, L., L. Cohn, D.H. Zhang, R. Homer, A. Ray, and P.
Ray. 1998. Essential role of nuclear factor kappaB in the in-
duction of eosinophilia in allergic airway inflammation. 
 
J.
Exp. Med.
 
 188:1739–1750.
20. Kureishi, Y., Z. Luo, I. Shiojima, A. Bialik, D. Fulton, D.J.
Lefer, W.C. Sessa, and K. Walsh. 2000. The HMG-CoA re-
ductase inhibitor simvastatin activates the protein kinase Akt
and promotes angiogenesis in normocholesterolemic animals.
 
Nat. Med.
 
 6:1004–1010.